We offer a technology that will redefine the treatment of oily waste through the use of microorganisms
Microciclo is in a constant process of evolution. Throughout our journey, we have won national and international awards and public notices.
The approval of Microciclo in the notice of economic subsidy for innovation in continuous flow, a joint initiative of the Ministry of Science, Technology and Innovations (MCTI) and the Financier of Studies and Projects - FINEP, aimed at boosting innovative projects with technological risk.
Access at: www.finep.gov.br
Approved among the top 3 companies in the Innovative Women Program of the Northeast stage.
Approved among the 28 companies in StartupNE Rio Grande do Norte
Approval of the Catalisa ICT Notice (2022), which comprises a journey of acceleration and promotion for the researcher, from the academy to the market.
Approved among the 10 startups selected for the Academy Industry Training (AIT/2020/2021) organized by the Swiss State Secretariat for Education, Research and Innovation (SERI) and the Ministry of Science, Technology, Innovation and Communication (MCTIC), of the Brazil. The program is carried out by swissnex Brazil, in partnership with the University of St. Gallen (Switzerland), and the National Council for Scientific and Technological Development (CNPq).
MicroCiclo was the winner in the “Accelerate” category of the MIT $100K Entrepreneurship Competition launched by Instituto Tecnológico de Buenos Aires, together with the MIT Sloan School of Management Latin America Office.
MicroCiclo was one of five finalists in the Pitch category of the MIT $100K Entrepreneurship Competition launched by Instituto Tecnológico de Buenos Aires, together with the MIT Sloan School of Management Latin America Office.
Approved among the 15 startups selected in the final phase of the call for proposals Centelha/RN (FINEP, MCTIC).
Approved for the second phase of the Conecta Startup Brasil pre-acceleration program of the Ministry of Science and Technology and Innovation in partnership with CNPq.